Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas.
about
Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism"Nonfunctional" Adrenal Tumors and the Risk for Incident Diabetes and Cardiovascular Outcomes: A Cohort Study.Clinical Guidelines for the Management of Adrenal Incidentaloma.The Recovery of Hypothalamic-Pituitary-Adrenal Axis Is Rapid in Subclinical Cushing Syndrome.Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up.Follow-up of patients with adrenal incidentaloma, in accordance with the European society of endocrinology guidelines: Could we be safe?First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS.Prednisolone has the same cardiovascular risk profile as hydrocortisone in glucocorticoid replacement.The presence of nonfunctioning adrenal incidentalomas increases arterial hypertension frequency and severity, and is associated with cortisol levels after dexamethasone suppression test.Resetting the Abnormal Circadian Cortisol Rhythm in Adrenal Incidentaloma Patients With Mild Autonomous Cortisol Secretion.Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center.Six controversial issues on subclinical Cushing's syndrome.The landscape of bilateral adrenal incidentalomas associated with subclinical hypercortisolism.Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma.Impact of hypercortisolism on skeletal muscle mass and adipose tissue mass in patients with adrenal adenomas.Fingernail and toenail clippings as a non-invasive measure of chronic cortisol levels in adult cancer survivors.Predictability of hypoadrenalism occurrence and duration after adrenalectomy for ACTH-independent hypercortisolism.Adrenalectomy was recommended for patients with subclinical Cushing's syndrome due to adrenal incidentaloma.Moderately impaired renal function increases morning cortisol and cortisol levels at dexamethasone suppression test in patients with incidentally detected adrenal adenomas.The Lateralizing Asymmetry of Adrenal Adenomas.Clinical Characteristics of Aldosterone- and Cortisol-Coproducing Adrenal Adenoma in Primary Aldosteronism.The impact of an adrenal incidentaloma algorithm on the evaluation of adrenal nodules
P2860
Q33579003-3242978D-CAA1-41BB-8983-11D2968A632CQ33752160-EBBB23A6-18BE-4379-AFC9-2D48E549D82BQ33889853-37EA425D-DA21-4F25-BEF2-EF8F6150AF9CQ37541418-2A3B8CF9-CBF0-44F3-8AF9-0102F8D8FFF1Q39088498-9251DEF6-C588-494F-995E-BA4EDFAC5167Q39287441-90E9386B-9DBD-4094-B4D0-7659B6DF9615Q40313813-6B2B7156-6E39-450E-B12F-5CA23DECCB03Q47139542-52A6FEEB-2C6E-43FB-8C39-0399384D0D37Q47363996-8ED48C98-BFAE-49BC-8F24-107EC8B3C2E7Q47675105-A027FE14-113E-44C6-9556-B9C59481638AQ48099922-258C8F68-45CF-49B0-993E-A58CB807C1A3Q48162982-26A8FB70-C08B-4C54-8E70-9700A76A6265Q48178018-22A6752A-FAAC-4148-9EAB-9DE6FC91E253Q48278106-9E93A8EA-4FD0-4DF9-AD55-647C1D1BE8A2Q48345771-BE311F33-E5D7-4F81-9F2D-BE5A639D2434Q49686466-41D0FE5C-9CA9-4889-B182-6AA759204898Q49904518-79658C55-0D99-4010-89B2-E7EDE5D62B37Q50071919-D37372F6-E5F7-4D0B-A64A-210E9EF7B425Q50908636-632A3F25-0B68-4FD9-AE1F-BEAF9E79B895Q55005911-415A596A-4BB1-459F-B074-EA583CA00C19Q55096183-6A852CC0-C3FD-44AF-AA49-F14632EDFDE6Q57645062-7D253CAE-0462-49F8-BFA9-51F42FB70EF8
P2860
Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cortisol as a marker for incre ...... ental adrenocortical adenomas.
@ast
Cortisol as a marker for incre ...... ental adrenocortical adenomas.
@en
Cortisol as a marker for incre ...... ental adrenocortical adenomas.
@nl
type
label
Cortisol as a marker for incre ...... ental adrenocortical adenomas.
@ast
Cortisol as a marker for incre ...... ental adrenocortical adenomas.
@en
Cortisol as a marker for incre ...... ental adrenocortical adenomas.
@nl
prefLabel
Cortisol as a marker for incre ...... ental adrenocortical adenomas.
@ast
Cortisol as a marker for incre ...... ental adrenocortical adenomas.
@en
Cortisol as a marker for incre ...... ental adrenocortical adenomas.
@nl
P2093
P2860
P356
P1476
Cortisol as a marker for incre ...... dental adrenocortical adenomas
@en
P2093
Barney Harrison
John Newell-Price
Matthew Bull
Miguel Debono
Richard J Ross
P2860
P304
P356
10.1210/JC.2014-3007
P407
P577
2014-12-01T00:00:00Z